STAAR Surgical Company (STAA): Price and Financial Metrics

STAAR Surgical Company (STAA): $72.70

-2.45 (-3.26%)

POWR Rating

Component Grades














  • STAA scores best on the Quality dimension, with a Quality rank ahead of 92.87% of US stocks.
  • The strongest trend for STAA is in Sentiment, which has been heading down over the past 179 days.
  • STAA ranks lowest in Momentum; there it ranks in the 16th percentile.

STAA Stock Summary

  • STAA's current price/earnings ratio is 165.67, which is higher than 96.26% of US stocks with positive earnings.
  • The price/operating cash flow metric for Staar Surgical Co is higher than 95.13% of stocks in our set with a positive cash flow.
  • With a year-over-year growth in debt of 196.89%, Staar Surgical Co's debt growth rate surpasses 94.45% of about US stocks.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Staar Surgical Co are PRLB, CPRX, ASPN, ECOM, and ITCI.
  • Visit STAA's SEC page to see the company's official filings. To visit the company's web site, go to

STAA Valuation Summary

  • In comparison to the median Healthcare stock, STAA's price/earnings ratio is 865.48% higher, now standing at 352.4.
  • Over the past 243 months, STAA's price/sales ratio has gone up 34.6.
  • STAA's price/sales ratio has moved up 34.6 over the prior 243 months.

Below are key valuation metrics over time for STAA.

Stock Date P/S P/B P/E EV/EBIT
STAA 2021-08-31 35.5 31.2 352.4 263.8
STAA 2021-08-30 34.4 30.2 341.3 255.4
STAA 2021-08-27 33.0 29.0 327.1 244.5
STAA 2021-08-26 31.4 27.6 311.2 232.3
STAA 2021-08-25 31.0 27.3 307.7 229.7
STAA 2021-08-24 31.4 27.6 312.0 233.0

STAA Growth Metrics

    Its 2 year cash and equivalents growth rate is now at 433.68%.
  • Its 5 year price growth rate is now at 410.75%.
  • Its 3 year net cashflow from operations growth rate is now at 474.08%.
STAA's revenue has moved up $152,937,000 over the prior 70 months.

The table below shows STAA's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2021-12-31 230.472 43.962 24.501
2021-09-30 217.469 55.014 22.906
2021-06-30 206.198 42.287 20.778
2021-03-31 179.025 35.888 11.039
2020-12-31 163.46 20.951 5.913
2020-09-30 156.345 11.194 8.965

STAA's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • STAA has a Quality Grade of B, ranking ahead of 92.6% of graded US stocks.
  • STAA's asset turnover comes in at 0.762 -- ranking 41st of 186 Medical Equipment stocks.
  • NVNO, ADMT, and BLFS are the stocks whose asset turnover ratios are most correlated with STAA.

The table below shows STAA's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-10-01 0.762 0.772 0.342
2021-07-02 0.784 0.764 0.341
2021-04-02 0.734 0.741 0.208
2021-01-01 0.713 0.724 0.110
2020-10-02 0.722 0.722 0.087
2020-07-03 0.720 0.722 0.056

STAA Price Target

For more insight on analysts targets of STAA, see our STAA price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $147.00 Average Broker Recommendation 1.5 (Moderate Buy)

STAA Stock Price Chart Interactive Chart >

Price chart for STAA

STAA Price/Volume Stats

Current price $72.70 52-week high $163.08
Prev. close $75.15 52-week low $49.03
Day low $72.53 Volume 362,700
Day high $76.79 Avg. volume 501,965
50-day MA $62.97 Dividend yield N/A
200-day MA $86.37 Market Cap 3.48B

STAAR Surgical Company (STAA) Company Bio

STAAR Surgical Company designs, develops, manufactures, and sells implantable lenses for the eye, and delivery systems to deliver lenses into the eye. The company was founded in 1982 and is based in Monrovia, California.

STAA Latest News Stream

Event/Time News Detail
Loading, please wait...

STAA Latest Social Stream

Loading social stream, please wait...

View Full STAA Social Stream

Latest STAA News From Around the Web

Below are the latest news stories about Staar Surgical Co that investors may wish to consider to help them evaluate STAA as an investment opportunity.

STAAR Surgical stock rises 12% as Q4 sales soar 28% Y/Y

STAAR Surgical (STAA +11.7%) stock rose following its earnings results, where Q4 net sales grew 28% Y/Y to $59M. The company said the increase was driven by ICL sales and unit growth of 33% and 36%, respectively, as compared to the prior year period. Other product sales decreased 3% compared to...

Seeking Alpha | February 24, 2022

I Ran A Stock Scan For Earnings Growth And STAAR Surgical (NASDAQ:STAA) Passed With Ease

It's only natural that many investors, especially those who are new to the game, prefer to buy shares in 'sexy' stocks...

Yahoo | February 24, 2022

STAAR Surgical Non-GAAP EPS of $0.19 beats by $0.03, revenue of $59M misses by $0.21M

STAAR Surgical press release (NASDAQ:STAA): Q4 Non-GAAP EPS of $0.19 beats by $0.03.Revenue of $59M (+28.3% Y/Y) misses by $0.21M.

Seeking Alpha | February 23, 2022

STAAR Surgical Reports Fourth Quarter and Full Year 2021 Results

LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today reported financial results for the fourth quarter and fiscal year ended December 31, 2021. Fourth Quarter 2021 Overview Net Sales of $59.0 Million Up 28% from the Prior Year Quarter ICL Sales of $53.0 Million Up 33% from the Prior Year Quarter ICL Units Up 36% from the Prior Year Quarter Gross Margin a

Business Wire | February 23, 2022

Staar Surgical (STAA) Q4 Earnings Top Estimates

Staar Surgical (STAA) delivered earnings and revenue surprises of 18.75% and 0.50%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Yahoo | February 23, 2022

Read More 'STAA' Stories Here

STAA Price Returns

1-mo N/A
3-mo -9.02%
6-mo -20.37%
1-year -52.33%
3-year 147.45%
5-year 573.15%
YTD -20.37%
2021 15.25%
2020 125.25%
2019 10.22%
2018 105.87%
2017 42.86%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.5892 seconds.